Accessibility settings

JMIRx Med

PubMed-indexed overlay journal for preprints with post-review manuscript marketplace (What is JMIRx?).

Editor-in-Chief:

​Fuqing Wu, PhD, The University of Texas Health Science Center at Houston, School of Public Health, Texas, USA


JMIRx Med (ISSN 2563-6316), which has been accepted for indexing in PubMed and PubMed Central, is an innovative overlay journal to  MedRxiv and JMIR Preprints (other preprint servers are welcome) conceived to address the urgent need to make highly relevant scientific information available as early as possible without losing the quality of the peer-review process. JMIRx peer-reviews preprints and publishes their revised "version of record" with peer-review reports across a broad range of medical, clinical, and related health sciences. Unlike the majority of JMIR journals, papers published in this journal do not require a digital health focus, but we publish all research that qualifies for preprinting on MedRxiv. 

All JMIRx Med papers are rigorously peer-reviewed, copyedited and XML-tagged. Accepted papers are published along with the related Peer Review Reports and Author Responses to Peer Review Reports, providing an additional layer of transparency to the scholarly publishing process. 

To submit a preprint to JMIRx, authors can self-nominate their existing preprints for publication (which is the equivalent to a traditional journal submission), using the minimalistic JMIRx-Med submission form that essentially only points to the preprint (the preprint needs to be unpublished and should not be under consideration by a journal).

Preprints that have already been peer-reviewed by third-party such as PREreview, MetaRoR, etc do not require further peer-review (at the editors' discretion).

For more details on other submission pathways (including for papers not in MedRxiv) and peer-review options see How to submit to a JMIRx journal.

For more information on JMIRx please also see our Knowledge Base article "What is JMIRx?".  

 

 

Recent Articles

Hand displaying holographic human anatomy icons for medical analysis
#xPublicandGlobalHealth

Artificial intelligence (AI) is increasingly transforming multiple sectors, including public health. Recent years have witnessed a substantial increase in research on integrating AI into public health systems, reflecting a growing interest in its potential to improve surveillance, diagnostics, policy development, and health outcomes.

Elderly man with oxygen concentrator and pulse oximeter at home
Reviews

Long-term oxygen therapy (LTOT) improves outcomes in selected patients with severe chronic hypoxemia, but conventional LTOT uses fixed oxygen flow prescriptions that may not reflect changing needs during activity, sleep, or exacerbations. AI and automated oxygen systems may support continuous peripheral capillary oxygen saturation (SpO) monitoring, signal-quality assessment, and adaptive oxygen titration. Evidence comparing AI-driven and non-AI automated approaches across performance, clinical readiness, LTOT applicability, and equity remains limited.

We are working in partnership with